EAU 2013 - Programme Book - YouMed

Saturday
Saturday, 16 March - EAU Programme
130 Programme Book
Abstract Session
16.00 - 17.30 Renal tumours: Basic research in prognostic markers
Amber Hall 1-2 - Level S2
Poster Session 17
Chairs: P.F.A. Mulders, Nijmegen (NL)
S. Zastrow, Dresden (DE)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
* 193 High cytoplasmic and low nuclear expression of HIF-2α are associated with worse cancer specific survival
(CSS) in clear cell renal cell carcinoma
N. Kroeger, D.B. Seligson, S. Signoretti, H. Yu, F.D. Birkhäuser, C.E. Magyar, J. Huang, J. Riss, F.F. Kabbinavar,
A.S. Belldegrun, A.J. Pantuck (Los Angeles and Greifswald, Los Angeles, Boston, United States of America)
194 Identification of high risk patients with clear cell renal cell carcinoma based on interphase-FISH
J. Sanjmyatav, S. Matthes, M. Mühr, D. Sava, M. Sternal, H. Wunderlich, M. Gajda, M-O. Grimm, K. Junker
(Jena, Eisenach, Homburg, Germany)
195 Prognostic significance of EpCAM expression in renal tumors: A clinicopathological study of 948 cases
M. Maruschke, A. Zimpfer, S. Rehn, G. Kundt, A. Litzensberger, F. Dammert, H. Zettl, C. Stephan,
A. Erbersdobler, O.W. Hakenberg (Rostock, Berlin, Germany)
196 Prognostic significance of platelet derived growth factor-β receptor in localized clear cell renal cell
carcinoma
S. Park, M. Shim, D. Yoo, C. Song, B. Hong, J.H. Hong, C-S. Kim, H. Ahn (Seoul, South Korea)
197 Aberrant glycosylation of N-glycan on immunoglobulin closely relates survival of the patients with renal
cell carcinoma
S. Hatakeyama, Y. Tobisawa, T. Yoneyama, K. Mori, T. Yoneyama, Y. Hashimoto, T. Koie, N. Tsuchiya,
T. Habuchi, M. Amano, S-I. Nishimura, C. Ohyama (Hirosaki, Akita, Hokkaido, Japan)
* 198 Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of
patients with clear cell renal cell carcinoma
H. Tezval, K. Gebauer, I. Peters, N. Dubrowinskaja, J. Hennenlotter, M. Abbas, R. Scherer, A.S. Merseburger,
A. Stenzl, M.A. Kuczyk, J. Serth (Hanover, Tübingen, Germany)
199 Vasohibin-1 is a novel independent predictor of disease-free survival in curatively operated renal cell
carcinoma patients
Y. Miyaji, N. Kanomata, Y. Sato, S. Kin, S. Ohira, M. Fujita, H. Yakushiji, K. Fukumoto, S. Shimizu, M. Kaifu,
T. Fujii, Y. Jo, T. Yokoyama, T. Moriya, A. Nagai (Kurashiki, Sendai, Japan)
200 Expression of MHC molecule CD1d in renal cell carcinoma (RCC) is associated poorer cancer-specific and
overall survival
T.W. Chong, M.Y. Sim, H.H. Huang, A.R. Lazaro, A.A. Thike, P.H. Tan (Singapore, Singapore)
201 Withdrawn
202 Phosphodiesterase-5- inhibition protects against ischemia-reperfusion acute kidney injury: In-vivo study
O. Nativ, I. Sukhotnik, R. Suhotnik, H. Awad, S. Heyman, Z. Abassi, O. Nativ (Haifa, Jerusalem, Israel)